Aurobindo Pharma Executive and Leadership Team

November, 2026

Leadership Overview

Aurobindo Pharma has 6 executives leading key functions including biologics strategy, administrative operations, financial oversight, fiscal planning, API manufacturing, and information technology.

Focused on delivering high-quality generic medications globally, Aurobindo Pharma maintains a commitment to therapeutic excellence through the development of antibiotics, antiretrovirals, and specialized pharmaceutical ingredients for diverse international markets.

Leadership Roles at Aurobindo Pharma

  • Chief Executive Officer - Biologics, Vaccines and Peptides - Satakarni Makkapati
  • EA and Admin To Chief Executive Officer - Kuoni Singh
  • Chief Financial Officer - Santhanam Subramanian
  • Deputy Chief Financial Officer - Vimlesh Maheshwari
  • Chief Operating Officer API Division - Anil Jain
  • Manager, Information Technology - Vijay Kondakkagari
  • Satakarni Makkapati - Chief Executive Officer - Biologics, Vaccines and Peptides

    Satakarni Makkapati, the Chief Executive Officer - Biologics, Vaccines and Peptides at Aurobindo Pharma, directs the strategic expansion of complex therapeutic portfolios. Overseeing research and development initiatives, the Chief Executive Officer - Biologics, Vaccines and Peptides ensures the successful commercialization of advanced vaccine platforms and peptide-based treatments. This leadership role involves navigating rigorous regulatory landscapes across global markets to maintain competitive positioning in the biotechnology sector. By aligning scientific innovation with manufacturing capabilities, Satakarni Makkapati drives the delivery of life-saving medications to patients worldwide. The Chief Executive Officer - Biologics, Vaccines and Peptides also collaborates with internal technical teams to optimize production efficiency for high-value pharmaceutical assets. Through this focused approach, the executive secures long-term growth for the biologics division while upholding stringent quality standards required for international pharmaceutical distribution.

    Kuoni Singh - EA and Admin To Chief Executive Officer

    Kuoni Singh, the EA and Admin To Chief Executive Officer at Aurobindo Pharma, manages critical executive workflows and organizational communication channels. Coordinating high-level administrative functions, the EA and Admin To Chief Executive Officer facilitates seamless interaction between the executive office and various global departments. This role involves prioritizing complex scheduling requirements and ensuring the efficient execution of corporate governance protocols. By streamlining internal processes, Kuoni Singh supports the strategic objectives of the leadership team and enhances overall operational productivity. The EA and Admin To Chief Executive Officer also monitors project timelines to ensure alignment with company-wide milestones. Through meticulous attention to detail and proactive management of executive resources, the professional maintains the stability of the corporate office. This position remains essential for the effective functioning of the leadership hierarchy within the expansive pharmaceutical manufacturing environment.

    Santhanam Subramanian - Chief Financial Officer

    Santhanam Subramanian, the Chief Financial Officer at Aurobindo Pharma, oversees the global financial health and capital allocation strategies of the organization. Managing fiscal reporting and investor relations, the Chief Financial Officer ensures transparency and compliance with international accounting standards. This leadership role involves evaluating investment opportunities in pharmaceutical manufacturing and assessing the financial viability of new therapeutic product launches. By optimizing the balance sheet and managing liquidity, Santhanam Subramanian supports the company's aggressive growth trajectory in the generic drug market. The Chief Financial Officer also coordinates with the board to define long-term financial goals and risk management frameworks. Through rigorous analysis of market trends and operational costs, the executive maintains the fiscal discipline necessary for sustained profitability. This oversight remains vital for the continued expansion of the company's footprint across diverse therapeutic areas and international regions.

    Vimlesh Maheshwari - Deputy Chief Financial Officer

    Vimlesh Maheshwari, the Deputy Chief Financial Officer at Aurobindo Pharma, executes detailed financial planning and internal audit functions to support corporate stability. Analyzing operational expenditures and revenue streams, the Deputy Chief Financial Officer provides actionable insights for cost-reduction initiatives across manufacturing facilities. This role involves supervising regional financial teams to ensure accurate reporting and adherence to budgetary constraints. By monitoring cash flow and working capital requirements, Vimlesh Maheshwari enables the organization to maintain agility in a volatile pharmaceutical market. The Deputy Chief Financial Officer also assists in the preparation of financial statements and supports the broader finance department during complex audits. Through consistent evaluation of financial performance metrics, the executive strengthens the company's internal control environment. This position contributes significantly to the overall financial integrity and strategic decision-making processes within the global pharmaceutical enterprise.

    Anil Jain - Chief Operating Officer API Division

    Anil Jain, the Chief Operating Officer API Division at Aurobindo Pharma, directs the large-scale production and supply chain logistics for active pharmaceutical ingredients. Overseeing manufacturing excellence, the Chief Operating Officer API Division ensures that production facilities meet global quality standards while maximizing output efficiency. This leadership role involves managing complex procurement networks and optimizing the synthesis processes for essential pharmaceutical components. By driving continuous improvement initiatives, Anil Jain enhances the reliability of the supply chain for antibiotics and other critical therapeutic areas. The Chief Operating Officer API Division also coordinates with quality assurance teams to maintain regulatory compliance across all manufacturing sites. Through strategic oversight of production capacity and resource allocation, the executive supports the company's ability to meet global demand for high-quality ingredients. This operational focus remains central to the company's competitive advantage in the generic pharmaceutical industry.

    Vijay Kondakkagari - Manager, Information Technology

    Vijay Kondakkagari, the Manager, Information Technology at Aurobindo Pharma, architects the digital infrastructure required to support global pharmaceutical operations. Implementing secure data management systems, the Manager, Information Technology ensures the integrity and availability of critical research and manufacturing information. This role involves overseeing cybersecurity protocols and upgrading enterprise software to improve cross-departmental collaboration. By integrating advanced technology solutions, Vijay Kondakkagari enables the company to streamline complex workflows and enhance data-driven decision-making. The Manager, Information Technology also manages the technical support teams responsible for maintaining the stability of the company's digital assets. Through the deployment of scalable IT solutions, the executive supports the company's mission to deliver high-quality medications efficiently. This leadership role remains essential for protecting intellectual property and ensuring the seamless operation of the company's global network of manufacturing and research facilities.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding Aurobindo Pharma Top Executives and Leadership Team

    Who leads Aurobindo Pharma?
    Aurobindo Pharma is led by Satakarni Makkapati (Chief Executive Officer - Biologics, Vaccines and Peptides), along with executives such as Kuoni Singh (EA and Admin To Chief Executive Officer) and Santhanam Subramanian (Chief Financial Officer).
    Who is part of Aurobindo Pharma’s executive team?
    The executive team of Aurobindo Pharma includes leaders such as Satakarni Makkapati (Chief Executive Officer - Biologics, Vaccines and Peptides), Kuoni Singh (EA and Admin To Chief Executive Officer), Santhanam Subramanian (Chief Financial Officer) and other senior executives.
    How many executives does Aurobindo Pharma have?
    Aurobindo Pharma has 6 executives leading key business areas.
    What roles are included in Aurobindo Pharma’s leadership team?
    The leadership team of Aurobindo Pharma includes roles such as Chief Executive Officer - Biologics, Vaccines and Peptides, EA and Admin To Chief Executive Officer, Chief Financial Officer, Deputy Chief Financial Officer, Chief Operating Officer API Division.